Abstract:Metastatic Prostate Cancer (mPCa) is associated with a poor patient prognosis. mPCa spreads throughout the body, often to bones, with spatial and temporal variations that make the clinical management of the disease difficult. The evolution of the disease leads to spatial heterogeneity that is extremely difficult to characterise with solid biopsies. Imaging provides the opportunity to quantify disease spread. Advanced image analytics methods, including radiomics, offer the opportunity to characterise heterogeneity beyond what can be achieved with simple assessment. Radiomics analysis has the potential to yield useful quantitative imaging biomarkers that can improve the early detection of mPCa, predict disease progression, assess response, and potentially inform the choice of treatment procedures. Traditional radiomics analysis involves modelling with hand-crafted features designed using significant domain knowledge. On the other hand, artificial intelligence techniques such as deep learning can facilitate end-to-end automated feature extraction and model generation with minimal human intervention. Radiomics models have the potential to become vital pieces in the oncology workflow, however, the current limitations of the field, such as limited reproducibility, are impeding their translation into clinical practice. This review provides an overview of the radiomics methodology, detailing critical aspects affecting the reproducibility of features, and providing examples of how artificial intelligence techniques can be incorporated into the workflow. The current landscape of publications utilising radiomics methods in the assessment and treatment of mPCa are surveyed and reviewed. Associated studies have incorporated information from multiple imaging modalities, including bone scintigraphy, CT, PET with varying tracers, multiparametric MRI together with clinical covariates, spanning the prediction of progression through to overall survival in varying cohorts. The methodological quality of each study is quantified using the radiomics quality score. Multiple deficits were identified, with the lack of prospective design and external validation highlighted as major impediments to clinical translation. These results inform some recommendations for future directions of the field.

Radiomics in prostate cancer: an up-to-date review

Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics

Radiomics vs radiologist in prostate cancer. Results from a systematic review

Beyond diagnosis: is there a role for radiomics in prostate cancer management?

MRI-derived radiomics models for diagnosis, aggressiveness, and prognosis evaluation in prostate cancer

Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies

Radiomics in Prostate Cancer: Basic Concepts and Current State-of-the-art

[Advances in artificial intelligence-assisted MRI radiomics in the diagnosis and treatment of prostate cancer]

Advancements in MRI-Based Radiomics and Artificial Intelligence for Prostate Cancer: A Comprehensive Review and Future Prospects

Personalized management of prostate cancer: from molecular and imaging markers to radiogenomics

The Application of Radiomics and AI to Molecular Imaging for Prostate Cancer

Multiparametric magnetic resonance imaging of the prostate: Lights and shadows

Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach

Mri相关影像组学模型用于前列腺癌诊断、侵袭性和预后评估

Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Radiomic Models in Prostate Cancer Prognostication

Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects

Emerging Trends in AI and Radiomics for Bladder, Kidney, and Prostate Cancer: A Critical Review

Radiomics in Oncology, Part 2: Thoracic, Genito-Urinary, Breast, Neurological, Hematologic and Musculoskeletal Applications

Optimizing radiomics for prostate cancer diagnosis: feature selection strategies, machine learning classifiers, and MRI sequences

More than Meets the Eye: Using Textural Analysis and Artificial Intelligence as Decision Support Tools in Prostate Cancer Diagnosis—A Systematic Review